Richard C. Duke

Dr. Duke is a biotechnology executive, inventor, and serial entrepreneur with nearly fifteen years of experience in building, financing, and managing start-up biotechnology companies plus over twenty-five years of experience in biomedical research. He currently serves as CEO of Peptivir, a biopharmaceutical company developing a ‘universal’ vaccine platform. Dr. Duke is a Co-Founder and former CEO and President of GlobeImmune and has been involved in the formation of ApopLogic Pharmaceuticals, Sierra Neuropharmaceuticals, Newellink and MenoGeniX. These companies have raised more than $100 million in financing to date and have multiple products in human clinical trials. He is currently President and CEO of the Colorado Institute for Drug Device and Diagnostic Development and is a tenured faculty member in the University of Colorado Department of Medicine.